v3.22.1
Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net income $ 2,308,250 $ 1,472,331
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities (2,835,950) (3,794,220)
General and administrative expenses paid by related party under note payable 29,287  
Offering costs associated with derivative warrant liabilities 182,130 0
Interest income from investments held in Trust Account (11,571) (41,407)
Changes in assets and liabilities:    
Prepaid expenses (440,771) 233,791
Accounts payable 80,044 (11,309)
Accrued expenses 22,000 846,135
Franchise tax payable 104,159 70,444
Net cash used in operating activities (562,422) (1,224,235)
Cash Flows from Investing Activities    
Cash deposited in Trust Account (414,000,000) (414,000,000.0)
Net cash used in investing activities (414,000,000)  
Cash Flows from Financing Activities:    
Proceeds received from initial public offering, gross 414,000,000  
Proceeds received from private placement 6,140,000  
Proceeds from Convertible Note—related party   430,000
Repayment of note payable to related party (171,450)  
Offering costs paid (4,518,031)  
Net cash provided by financing activities 415,450,519 430,000
Net change in cash 888,097 (794,235)
Cash—beginning of the period 0 888,097
Cash—end of the period 888,097 $ 93,862
Supplemental disclosure of noncash activities:    
Offering costs included in accrued expenses 85,000  
Offering costs included in accounts payable 142,163  
Common Class B [Member]    
Supplemental disclosure of noncash activities:    
Offering costs paid in exchange for issuance of common stock to Sponsor 18,750  
Common Stock Class F [Member]    
Supplemental disclosure of noncash activities:    
Offering costs paid in exchange for issuance of common stock to Sponsor $ 6,250